Ashton Thomas Private Wealth
SER icon

Ashton Thomas Private Wealth’s Serina Therapeutics SER Stock Holding History

Ashton Thomas Private Wealth’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$178K Buy
+88,888
New +$206K ﹤0.01% 1224

Other funds holding SER

Avidian Wealth Enterprises
Avidian Wealth Enterprises Houston, Texas $3.59B AUM 17.8% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
Piscataqua Savings Bank
Piscataqua Savings Bank Portsmouth, New Hampshire $146M AUM 24.42% 1-Year Est. Return
Albion Financial Group
Albion Financial Group Salt Lake City, Utah $1.77B AUM 14.95% 1-Year Est. Return
Pacifica Partners
Pacifica Partners Surrey, Canada $332M AUM 43.09% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Ashton Thomas Private Wealth's SER Position: Q3 2026 in Review

Ashton Thomas Private Wealth opened a new position in Serina Therapeutics (SER) in Q3 2026: 88,888 shares worth $178K. The stake represents ﹤0.01% of the portfolio and ranks #1224 among its holdings.

9 funds tracked by Wall St. Rank hold SER as of Q3 2026.

  • Ashton Thomas Private Wealth held 88,888 shares of Serina Therapeutics worth $178K as of Q3 2026.
  • Serina Therapeutics was a new Ashton Thomas Private Wealth position in Q3 2026.
  • Serina Therapeutics made up ﹤0.01% of Ashton Thomas Private Wealth's portfolio in Q3 2026, its #1224 holding.
  • 9 funds tracked by Wall St. Rank held Serina Therapeutics as of Q3 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.